首页> 美国卫生研究院文献>Annals of Surgery >Survival Analysis of Pseudomyxoma Peritonei Patients Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

【2h】

Survival Analysis of Pseudomyxoma Peritonei Patients Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

机译：细胞减少性手术和高温腹膜内化学疗法治疗腹膜间皮瘤的生存分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objective:To evaluate the survival of patients with pseudomyxoma peritonei (PMP) treated by cytoreductive surgery and intraoperative hyperthermic intraperitoneal chemotherapy (HIPEC), and to identify factors with prognostic value.

机译：目的：评估细胞减灭术和术中高温腹膜内化疗（HIPEC）治疗的腹膜假性粘液瘤（PMP）患者的生存率，并确定具有预后价值的因素。

著录项

期刊名称 Annals of Surgery
作者
Robert M. Smeenk; Vic J. Verwaal; Ninja Antonini; Frans A. N. Zoetmulder;
展开▼
作者单位

展开▼
年(卷),期 2007(245),1
年度 2007
页码 104–109
总页数 6
原文格式 PDF
正文语种
中图分类外科学;
关键词

相似文献

外文文献
中文文献
专利

1. Overall survival of pseudomyxoma peritonei and peritoneal mesothelioma patients after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy can be predicted by computed tomography quantified sarcopenia [J] . Alexandre Galan, Pascal Rousset, Frederic Mercier, European Journal of Surgical Oncology: The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology . 2018,第11期

机译：通过计算断层扫描定量的SARCEPENIA可以预测白皮蛋白腹膜腹膜腹膜腹膜和腹膜间皮瘤患者的整体存活率
2. Validation of the Recent PSOGI Pathological Classification of Pseudomyxoma Peritonei in a Single-Center Series of 265 Patients Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy [J] . Baratti Dario, Kusamura Shigeki, Milione Massimo, Annals of surgical oncology . 2018,第2期

机译：验证由细胞射击手术和高温腹膜化疗治疗的265名患者的单中心系列PSEUDOUDYXOMA腹膜PSOGI病理分类
3. Preoperative carcinoembryonic antigen level predicts prognosis in patients with pseudomyxoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy [J] . CanbayE., IshibashiH., SakoS., World Journal of Surgery: Official Journal of the Societe Internationale de Chirurgie, Collegium Internationale Chirurgiae Digestivae, and of the International Association of Endocrine Surgeons . 2013,第6期

机译：术前癌胚抗原水平预测患有细胞功能性手术和高温腹膜化疗治疗的假瘤腹膜患者的预后
4. Efficacy of Intraperitoneal Perfusion Hyperthermic Chemotheraphy(CHIP)With Cisplatin Combined With Intraveuous Chemotherapy for Patients With Advanced Gastrointestinal Carcinoma [C] . The 3rd Asian congress on hyperthermic oncology and the 9th Chineses symposium on hyperthermic oncology . 2002

机译：腹腔灌注热化学疗法（CHIP）联合顺铂联合静脉化疗治疗晚期胃肠道癌的疗效
5. The Evolution of Hyperthermic Intraperitoneal Chemotherapy in The Setting of Advanced Ovarian Cancer [D] . Quindlen, Kevin J. 2019

机译：高温腹膜内化疗的演变在晚期卵巢癌的环境中
6. Factors influencing long‐term survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei originating from appendiceal neoplasms [O] . W. J. van Eden, N. F. M. Kok, P. Snaebjornsson, 2019

机译：影响阑尾肿瘤假性粘液瘤细胞减灭术和腹腔热液腹腔化疗后长期生存的影响因素
7. Survival Analysis of Pseudomyxoma Peritonei Patients Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy [O] . Smeenk, Robert M., Verwaal, Vic J., Antonini, Ninja, 2007

机译：细胞减少性手术和高温腹膜内化学疗法治疗腹膜脓毒症患者的生存分析

Survival Analysis of Pseudomyxoma Peritonei Patients Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

摘要

著录项

相似文献

相关主题

期刊订阅